p53	O
mutation	O
heterogeneity	O
in	O
cancer	B-Cancer
.	O

The	O
p53	O
gene	O
is	O
inactivated	O
in	O
about	O
50	O
%	O
of	O
human	O
cancers	B-Cancer
and	O
the	O
p53	O
protein	O
is	O
an	O
essential	O
component	O
of	O
the	O
cell	B-Cell
response	O
induced	O
by	O
genotoxic	O
stresses	O
such	O
as	O
those	O
generated	O
by	O
radiotherapy	O
or	O
chemotherapy	O
.	O

It	O
is	O
therefore	O
highly	O
likely	O
that	O
these	O
alterations	O
are	O
an	O
important	O
component	O
in	O
tumor	B-Cancer
resistance	O
to	O
therapy	O
.	O

The	O
particular	O
characteristics	O
of	O
these	O
alterations	O
,	O
80	O
%	O
of	O
which	O
are	O
missense	O
mutations	O
leading	O
to	O
functionally	O
heterogeneous	O
proteins	O
,	O
make	O
p53	O
a	O
unique	O
gene	O
in	O
the	O
class	O
of	O
tumor	B-Cancer
suppressor	O
genes	O
.	O

A	O
considerable	O
number	O
of	O
mutant	O
p53	O
proteins	O
probably	O
have	O
an	O
oncogenic	O
activity	O
per	O
se	O
and	O
therefore	O
actively	O
participate	O
in	O
cell	B-Cell
transformation	O
.	O

The	O
fact	O
that	O
the	O
apoptotic	O
and	O
antiproliferative	O
functions	O
of	O
p53	O
can	O
be	O
dissociated	O
in	O
certain	O
mutants	O
also	O
suggests	O
another	O
level	O
of	O
complexity	O
in	O
the	O
relationships	O
between	O
p53	O
inactivation	O
and	O
neoplasia	B-Cancer
.	O

